Tezspire All Set To Tackle Big Biologic Rivals In Severe Asthma
EU Approval Granted For AstraZeneca's Amgen-Partnered Therapy
With a European approval in the bag for Tezspire, AstraZeneca is looking for quick and successful launches of the severe asthma drug so it can mount a challenge to the other biologics in the space, notably Sanofi and Regeneron’s Dupixent.
